Argloyn Biosciences argolyn.com


Public lists: Pharma Startups (4732)

Argolyn Bioscience is a biopharmaceutical company dedicated to discovering and developing peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. One of its development candidates is ABS201, a peptide derivative currently in preclinical development for the treatment of schizophrenia.

Argolyn Bioscience is a biopharmaceutical company dedicated to discovering and developing peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders. One of its development candidates is ABS201, a peptide derivative cu...Show all

Company (Alive / Active)

Phone:

Fax:

Durham, 27701
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Argloyn Biosciences $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Argloyn Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Shanghai Sunway

China
Alive / ActiveShanghai Sunway Is a bioscience companyLogin to see details

Newron Pharmaceuticals

Italy
IPO / Went publicNewron Pharmaceuticals is a biopharmaceutical company focused on novel therapies for diseases of the Central Nervous System and pain. Newron is undertaking phase III trials with safinamide for the treatment of Parkinson's disease (PD) in conjunction with its partner, Merck Serono, which has exclusive worldwide rights to develop, manufacture and commercialize the compound in PD, Alzheimeru00b4s disease, and other therapeutic applications. Newron recently reported excellent results for its compoun...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)